1. Home
  2. SNOA vs SMX Comparison

SNOA vs SMX Comparison

Compare SNOA & SMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • SMX
  • Stock Information
  • Founded
  • SNOA 1999
  • SMX N/A
  • Country
  • SNOA United States
  • SMX Ireland
  • Employees
  • SNOA N/A
  • SMX N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • SMX Industrial Machinery/Components
  • Sector
  • SNOA Health Care
  • SMX Technology
  • Exchange
  • SNOA Nasdaq
  • SMX Nasdaq
  • Market Cap
  • SNOA 7.5M
  • SMX 6.7M
  • IPO Year
  • SNOA 2007
  • SMX N/A
  • Fundamental
  • Price
  • SNOA $4.55
  • SMX $1.36
  • Analyst Decision
  • SNOA
  • SMX
  • Analyst Count
  • SNOA 0
  • SMX 0
  • Target Price
  • SNOA N/A
  • SMX N/A
  • AVG Volume (30 Days)
  • SNOA 3.9M
  • SMX 6.3M
  • Earning Date
  • SNOA 11-06-2025
  • SMX 01-01-0001
  • Dividend Yield
  • SNOA N/A
  • SMX N/A
  • EPS Growth
  • SNOA N/A
  • SMX N/A
  • EPS
  • SNOA N/A
  • SMX N/A
  • Revenue
  • SNOA $14,912,000.00
  • SMX N/A
  • Revenue This Year
  • SNOA $23.00
  • SMX N/A
  • Revenue Next Year
  • SNOA $24.59
  • SMX N/A
  • P/E Ratio
  • SNOA N/A
  • SMX N/A
  • Revenue Growth
  • SNOA 17.43
  • SMX N/A
  • 52 Week Low
  • SNOA $1.75
  • SMX $1.10
  • 52 Week High
  • SNOA $6.92
  • SMX $5,925.93
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 55.76
  • SMX 26.18
  • Support Level
  • SNOA $4.45
  • SMX $1.10
  • Resistance Level
  • SNOA $4.74
  • SMX $2.16
  • Average True Range (ATR)
  • SNOA 0.27
  • SMX 0.47
  • MACD
  • SNOA -0.07
  • SMX 0.32
  • Stochastic Oscillator
  • SNOA 16.38
  • SMX 6.81

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

Share on Social Networks: